logo

For the Inventor, By the Inventor

Taipei, Taiwan

Klim King

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignees: Academia Sinica, Development Center for Biotechnology, Vitnovo, Inc.. Active years: 2019-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Klim King. Retrieved from https://idiyas.com/inventor/klim-king-h914fl2u

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Xizhi, TW (2020)
  • Taipei, TW (2019 - 2021)

Company Filing History:

goldMedal2 out of 726 
 
Academia Sinica
 patents
silverMedal1 out of 96 
 
Development Center for Biotechnology
 patents
bronzeMedal1 out of 1 
 
Vitnovo, Inc.
 patent

Years Active: 2019-2021

Loading Chart...
4 patents (USPTO):Explore Patents
1. 11020447 - Compositions, kits and methods for treating type II diabetes mellitus (2021-06-01),
2. 10561700 - Use of overground part ofKoenig in reducing blood glucose; extracts and compositions of overground part ofKoenig and their uses (2020-02-18),
3. 10408813 - Biosensor for detecting intracellular cyclic adenosine monophosphate (cAMP) and uses thereof (2019-09-10),
4. 10392357 - Glucagon-like peptide 1 modulator and uses thereof (2019-08-27),

Title: Innovations by Klim King in Diabetes Treatment

Introduction

Klim King is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of diabetes treatment, holding a total of 4 patents. His work focuses on innovative methods and compositions aimed at managing type II diabetes mellitus.

Latest Patents

Klim King's latest patents include groundbreaking methods for treating type II diabetes mellitus. One of his inventions discloses methods for using an extract of Koenig alongside a blood glucose reduction agent to synergistically lower blood glucose levels in individuals with type II diabetes. Another patent emphasizes the use of the overground part of Koenig in reducing blood glucose and increasing insulin levels, providing a novel approach to treating and preventing diabetes without excessively lowering blood glucose in fasting subjects.

Career Highlights

Throughout his career, Klim King has worked with reputable companies such as Academia Sinica and Vitnovo, Inc. His experience in these organizations has contributed to his expertise in diabetes research and innovation.

Collaborations

Klim has collaborated with notable coworkers, including Yu-Yuan Wu and Lung-Yu Kuan, enhancing the impact of his research through teamwork and shared knowledge.

Conclusion

Klim King's innovative work in diabetes treatment showcases his dedication to improving health outcomes for individuals with type II diabetes. His patents reflect a commitment to advancing medical science and providing effective solutions for managing this prevalent condition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…